AML3D signs new two-year UK/Europe distro deal

Wire arc additive manufacturing business AML3D has announced Arc Additive as a new, non-exclusive distributor in the UK and European markets. AML3D told investors on Monday that its European growth strategy is in alignment with the Scottish-based solutions supplier’s manufacturing expertise and target markets. The deal runs for two years.  The Adelaide-based company announced plans…

Details

Best of the week — the five most popular stories among readers, July 21 – 25, 2025

What were the five biggest stories of the week? Here’s what visitors to @AuManufacturing were reading. 5) Federal, SA governments tip in an extra $275 million for Whyalla steelworks as sales process continues The federal and South Australian governments have announced an additional $275 million in funding to support operations, workers and suppliers at the Whyalla Steelworks…

Details

Training Centre for Battery Recycling launched at University of Adelaide

The new Australian Research Council (ARC) Training Centre for Battery Recycling, based at University of Adelaide’s School of Chemical Engineering and led by Professor Shizhang Qiao, officially launched this week. The centre’s lifespan runs from 2024 – 2029 and its work covers five themes:  Pre-treatment and second-life management;  Recycling spent batteries to materials; Resynthesizing materials…

Details

PWR founder returns to work

The founder and Managing Director of ASX-listed cooling technology company PWR Holdings is making a phased return to work after taking medical leave in April due to treatment of an acute medical condition.  In a statement on Thursday, the company said Weel is continuing his recovery and will share executive responsibilities with Acting CEO Matthew…

Details

Government commits $150 million to medical innovation fund

The National Reconstruction Fund Corporation has committed $150 million to Brandon Capital to accelerate Australian medical innovation commercialisation, according to an announcement on Thursday. The investment will be allocated to Brandon Capital’s BioCatalyst 6 fund and will support early and late-stage Australian medical science companies developing therapeutics, medical devices and vaccines. NRFC chief executive David…

Details